IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,971 | -1.6% | 308 | -11.0% | 0.00% | 0.0% |
| Q2 2023 | $14,196 | +65.5% | 346 | +44.2% | 0.00% | +100.0% |
| Q1 2023 | $8,578 | +97.5% | 240 | +108.7% | 0.00% | 0.0% |
| Q4 2022 | $4,344 | -45.7% | 115 | -37.2% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +300.0% | 183 | +221.1% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 57 | +185.0% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 20 | -80.4% | 0.00% | -100.0% |
| Q3 2021 | $3,000 | +200.0% | 102 | +537.5% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 16 | -65.2% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 46 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | – | 46 | – | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 20 | -54.5% | 0.00% | -100.0% |
| Q2 2019 | $2,000 | -33.3% | 44 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $3,000 | +50.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |